Medical diagnostic assays for testing for the presence of biomarkers in blood or bodily fluids for diagnosing gynecological diseases, namely endometriosis; Medical diagnostic assays for testing for the presence of biomarkers in uterine tissue for determining a patient's personalized and optimal embryo implantation time and for determining a patient's personalized treatment plan, as well as the composition of microbiome, including presence of normal lactobacillus and targeted pathogenic bacteria, namely, Escherichia, Klebsiella, Enterococcus, Streptococcus, Mycoplasma, Chlamydia, Ureaplasma, Neisseria, Staphylococcus, and Gardnerella; Medical diagnostic assays for testing for the presence of biomarkers in uterine and vaginal tissue for determining a patient's personalized treatment plan; for bacterial, fungal and resistance markers for determining a personalized treatment plan; Medical diagnostic assays for testing for the presence of biomarkers in human biological material for diagnosing gynecological diseases, namely, primary ovarian insufficiency; Pharmaceuticals, namely, therapeutic drugs for treating endometriosis, infertility, and gynecological diseases and disorders; Providing medical information in the field of gynecology; medical information services in the gynecological field; medical testing services for diagnostic purposes in the field of gynecology, namely, testing services for detecting endometritis, a woman's personalized embryo implantation time, and/or Pelvic Inflammatory Disease and antibiotic resistance either post-partum or in cases of unexplained infertility; medical diagnostic services for gynecological diseases and disorders, namely, for detecting endometriosis by identifying and analyzing biomarkers for diagnostic and/or treatment purposes; medical assessment services, namely, health assessment of a patient's remaining childbearing years based on patient-specific health information.; Medical devices, namely, surgical and nonsurgical devices for treating endometriosis, infertility, and gynecological diseases and disorders.
Medical diagnostic assays for testing for the presence of biomarkers in human biological material for diagnosing gynecological diseases, namely primary ovarian insufficiency.
Providing medical information in the field of gynecology; medical information services in the gynecological field; medical assessment services, namely, health assessment and predictive services for estimating remaining childbearing years based on patient-specific health information.
Medical diagnostic assays for testing for the presence of biomarkers in uterine tissue for determining a patient's personalized treatment plan; medical diagnostic assays for testing for the presence normal lactobacillus and targeted pathogenic bacteria, namely Escherichia, Klebsiella, Enterococcus, Streptococcus, Mycoplasma, Chlamydia, Ureaplasma, Neisseria, Staphylococcus, and Gardnerella.; Providing medical information in the field of gynecology; medical information services in the gynecological field, namely endometritis; medical diagnostic services for gynecological conditions; medical testing services for diagnostic purposes in the field of gynecology; medical testing services, namely testing services for detecting endometritis, Pelvic Inflammatory Disease and antibiotic resistance either post-partum or in cases of unexplained infertility.
Medical diagnostic assays for testing for the presence of biomarkers in uterine and vaginal tissue for determining a patient's personalized treatment plan; medical diagnostic assays for testing of uterine and vaginal tissue for bacterial, fungal and resistance markers for determining a personalized treatment plan.; Providing medical information in the field of gynecology; medical information services in the gynecological field, namely endometritis; medical diagnostic services for gynecological conditions; medical testing services for diagnostic purposes in the field of gynecology; medical testing services, namely testing services for detecting endometritis, Pelvic Inflammatory Disease and antibiotic resistance either post-partum or in cases of unexplained infertility.
Medical diagnostic assays for testing the presence of biomarkers in blood for diagnosing gynecological diseases, namely endometriosis.; Providing medical information in the field of gynecology; medical information services in the gynecological field; medical diagnostic services for gynecological diseases; medical testing services for diagnostic purposes in the field of gynecology; medical testing services, namely, diagnostic services for detecting endometriosis by identifying and analyzing biomarkers for diagnostic and/or treatment purposes.
Medical diagnostic assays for testing for the presence of biomarkers in uterine tissue for determining a patient's personalized and optimal embryo implantation time.; Providing medical information in the field of gynecology; medical information services in the gynecological field, namely reproductive endocrinology; medical diagnostic services for gynecological conditions; medical testing services for diagnostic purposes in the field of gynecology; medical testing services, namely testing services for detecting a woman's personalized embryo implantation time.
Medical diagnostic assay test and analysis for the presence of biomarkers in blood for diagnosing gynecological diseases, namely endometriosis.; Providing medical information in the field of gynecology; medical information services in the gynecological field; medical diagnostic services for gynecological diseases; medical testing services for diagnostic purposes in the field of gynecology; medical testing services, namely diagnostic services for detecting endometriosis by identifying and analyzing biomarkers for diagnostic or treatment purposes.
Cookie Preferences
We use cookies (including Google Analytics) to improve our site and understand how visitors use it.